Research

Hormonal

Small molecule activators of SIRT1 (SRT501 and SRT1720) replicate the molecular signaling pathways of calorie restriction in vivo, specifically by enhancing mitochondrial biogenesis, improving metabolic signaling, and blunting pro-inflammatory pathways.

This research suggests that specific compounds (SRT501, SRT1720) can mimic the metabolic benefits of calorie restriction, such as improved insulin sensitivity and reduced inflammation, in obese rodent models. While promising for treating Type 2 Diabetes, these are experimental drugs, not supplements. The findings highlight that activating SIRT1 is a key mechanism by which calorie restriction improves health, validating the biological importance of this pathway.

ModerateSupportsMEDIUM confidence
Here we demonstrate that SIRT1 activators recapitulate many of the molecular events downstream of CR in vivo, such as enhancing mitochondrial biogenesis, improving metabolic signaling pathways, and blunting pro-inflammatory pathways in mice fed a high fat, high calorie diet.
J. Joshua Smith et al. · BMC Systems Biology · 2009

Why this rating

The study uses rodent models (mice, rats) and cell lines, not human clinical trials, limiting direct applicability to humans.

Source

Small molecule activators of SIRT1 replicate signaling pathways triggered by calorie restriction in vivo

J. Joshua Smith et al. · BMC Systems Biology · 2009

DOI 10.1186/1752-0509-3-31

mechanism_onlyCited 211×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →